Market Place
Sourcing Support
AMAG Loses Insurance Claim For Pfizer Plant Manufacturing Issue
22 Aug 2024 //
FIERCE PHARMA
Covis granted FDA hearing over premature-birth med Makena
21 Aug 2021 //
FIERCEPHARMA
FDA, unmoved by new meta-analysis, still recommends Makena withdrawal
30 Mar 2021 //
RAPS
AMAG Pharmaceuticals Files Submission in Response To theFDA’s Notice
14 Dec 2020 //
GLOBENEWSWIRE
Covis Group Completes Acquisition of AMAG Pharmaceuticals
16 Nov 2020 //
PRNEWSWIRE
Covis Group Completes Acquisition of AMAG Pharmaceuticals
16 Nov 2020 //
BIOSPACE
AMAG Pharmaceuticals Requests Hearing to Maintain Makena®
14 Oct 2020 //
GLOBENEWSWIRE
FDA moves to pull preterm birth drug from market
07 Oct 2020 //
BIOPHARMADIVE
FDA seeks withdrawal of Makena, generics from market
06 Oct 2020 //
RAPS
FDA urges removal of Amag drug from market amid $500M acquisition
05 Oct 2020 //
BIZJOURNALS
Covis Group to acquire AMAG Pharmaceuticals in $647m deal
05 Oct 2020 //
PHARMAFILE
Covis Group to acquire AMAG Pharmaceuticals in $647m deal
05 Oct 2020 //
PHARMAFILE
Amag Pharma up 41% on takeover rumors
30 Sep 2020 //
SEEKING ALPHA
Palatin Technologies Announces Mutual Termination of License Agreement with AMAG
27 Jul 2020 //
PRNEWSWIRE
AMAG Pharmaceuticals Completes Divestment of Women’s Health Assets
27 Jul 2020 //
GLOBENEWSWIRE
AMAG signs European partner as they hunt cash to get their lead drug through the clinic
24 Jul 2020 //
ENDPTS
AMAG & Norgine B.V. Enter Into Exclusive Licensing Agreement Ciraparantag
23 Jul 2020 //
GLOBENEWSWIRE
AMAG Announces Presentation of Ciraparantag Data at the International Society
13 Jul 2020 //
MARKETWATCH
AMAG Completes Sale of its Rights to Intrarosa® to Millicent for up to $125M
21 May 2020 //
GLOBENEWSWIRE
Makena mess, CEO exit; now, AMAG loses CMO
06 Mar 2020 //
FIERCE BIOTECH
AMAG CMO hits the exit just as biotech searches for new CEO to right
04 Mar 2020 //
REUTERS
AMAG`s CEO departure, drug dumps may not right the ship, analyst says
10 Jan 2020 //
FIERCE PHARMA
Amag to divest two of three women`s health drugs, CEO to step down
10 Jan 2020 //
REUTERS
Makena Withdrawal? A Look at the Timeline and Other Accelerated Approvals
01 Nov 2019 //
RAPS
FDA panel backs withdrawal of Amag drug to prevent preterm birth
31 Oct 2019 //
BIOPHARMADIVE
AMAG Pharmaceuticals Stock Trading Halted Today
29 Oct 2019 //
BIOSPACE
Amag Pharma shares halted pending outcome of Ad Com meeting
29 Oct 2019 //
SEEKINGALPHA
Vyleesi™ Phase 3 Data To Be Presented At The 13th European Society
16 Oct 2019 //
BIOSPACE
AMAG Pharmaceutical Announces Settlement Agreement with Caligan Partners LP
08 Oct 2019 //
GLOBENEWSWIRE
Medicure Announces Preferred Pricing Agreement for Zypitamag™
04 Oct 2019 //
PR NEWSWIRE
FDA review of troubled drug could hobble AMAG in proxy fight
27 Sep 2019 //
FIERCE PHARMA
Embattled AMAG braces for October FDA Makena adcom, but it need not worry
24 Sep 2019 //
ENDPTS
AMAG, activist investor lock horns amid board takeover attempt
24 Sep 2019 //
FIERCE PHARMA
Activist Investor Seek Four Board Seats at Amag Pharmaceuticals
03 Sep 2019 //
BLOOMBERG
AMAG Pharma introduces Vyleesi for treatment of acquired, generalized HSDD
28 Aug 2019 //
PHARMABIZ
Caligan Partners Is Said to Have Built Stake in Amag Pharma
15 Aug 2019 //
THESTREET
Amag`s female libido injectable therapy to sell at $899
07 Aug 2019 //
REUTERS
AMAG wins FDA nod for Vyleesi
22 Jun 2019 //
FIERCE PHARMA
AMAG Pharmaceuticals` Vyleesi (Bremelanotide) Receives Approval in US
21 Jun 2019 //
FDA
AMAG Pharma Appoints EVP
02 May 2018 //
GLOBENEWSWIRE
US FDA approves Makena injection using ‘smaller, non-visible needle’ tech
20 Feb 2018 //
IN PHARMATECHNOLOGIST
Amag`s digital revamp puts consumer tactics to work for pharma
09 Oct 2017 //
FIERCE PHARMA
AMAG to hire 150 new sales reps to tout newly licensed women`s health "Intrarosa
15 Feb 2017 //
FIERCE PHARMA
Why Did That Drug Price Increase 6,000%? It`s The Law
11 Feb 2017 //
FORBES
AMAG Pharma closes licensing pact with Palatin Technologies
06 Feb 2017 //
PHARMABIZ
Exclusive: Sanofi to unveil challenge to Medivation`s board - sources
25 May 2016 //
REUTERS
US FDA approves AMAG Pharma`s single-dose Makena to reduce risk of preterm birth
24 Feb 2016 //
PHARMABIZ
Palatin to Hold Licensing Agreement for North American Rights to Rekynda™
10 Jan 2016 //
PR NEWSWIRE
Up and down the ladder: The latest comings and goings
06 Jan 2016 //
STAT
FDA again rejects single-dose use of AMAG`s Makena
19 Nov 2015 //
REUTERS
AMAG Pharmaceuticals acquires Cord Blood Registry
19 Aug 2015 //
PHARMABIZ
AMAG Pharma to acquire rights to an orphan drug candidate, DIF from Velo Bio
25 Jul 2015 //
PHARMABIZ
AMAG Announces Further Expansion of Maternal Health Portfolio
22 Jul 2015 //
BIOSPACE
Nine Boston Biotechs That Are Actually Profitable
22 Jul 2015 //
BIOSPACE
FDA Seeks More Info Before Approving AMAG Pharmaceuticals, Single-Dose Vial of Makena
28 May 2015 //
BIOSPACE
Tiny drugmakers top list of most profitable, but Shire and Gilead are there, too
07 May 2015 //
FIERCE PHARMA
